Xiu R et al. |
[Elimination of cholesterol in human endothelial cells]. |
1997 |
Zhonghua Yi Xue Za Zhi |
pmid:9772537
|
DuSell CD and McDonnell DP |
27-Hydroxycholesterol: a potential endogenous regulator of estrogen receptor signaling. |
2008 |
Trends Pharmacol. Sci. |
pmid:18722677
|
Nelson ER et al. |
Cholesterol and breast cancer pathophysiology. |
2014 |
Trends Endocrinol. Metab. |
pmid:25458418
|
Umetani M and Shaul PW |
27-Hydroxycholesterol: the first identified endogenous SERM. |
2011 |
Trends Endocrinol. Metab. |
pmid:21353593
|
Zhu D et al. |
The ROS-mediated activation of STAT-3/VEGF signaling is involved in the 27-hydroxycholesterol-induced angiogenesis in human breast cancer cells. |
2016 |
Toxicol. Lett. |
pmid:27856279
|
Kim SM et al. |
27-Hydroxycholesterol and 7alpha-hydroxycholesterol trigger a sequence of events leading to migration of CCR5-expressing Th1 lymphocytes. |
2014 |
Toxicol. Appl. Pharmacol. |
pmid:24370436
|
Guan JZ et al. |
Clofibrate, a peroxisome-proliferator, enhances reverse cholesterol transport through cytochrome P450 activation and oxysterol generation. |
2003 |
Tohoku J. Exp. Med. |
pmid:14690017
|
Meaney S et al. |
On the origin of the cholestenoic acids in human circulation. |
2003 |
Steroids |
pmid:12957664
|
Shoda J et al. |
Synthesis of potential C27-intermediates in bile acid biosynthesis and their deuterium-labeled analogs. |
1993 |
Steroids |
pmid:8475516
|
Wassif CA et al. |
27-Hydroxylation of 7- and 8-dehydrocholesterol in Smith-Lemli-Opitz syndrome: a novel metabolic pathway. |
2003 |
Steroids |
pmid:12906934
|